Clinical Trials Browser

Terminated × motexafin gadolinium × Lymphoid × Clear all

NCT00076401 2014-06-26

A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell